N-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide

C46H48N14O4S6 — CID 144630605

IUPACN-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide
SMILESCc1ccnc(CC(=O)Nc2nnc(CC3CC(Cc4nnc(NC(=O)Cc5ccccn5)s4)C3)s2)c1.Cc1nnc(NC(=O)Cc2cccs2)s1.O=C(Cc1cccs1)Nc1nnc(CC2CC2)s1
InChIInChI=1S/C25H26N8O2S2.C12H13N3OS2.C9H9N3OS2/c1-15-5-7-27-19(8-15)14-21(35)29-25-33-31-23(37-25)12-17-9-16(10-17)11-22-30-32-24(36-22)28-20(34)13-18-4-2-3-6-26-18;16-10(7-9-2-1-5-17-9)13-12-15-14-11(18-12)6-8-3-4-8;1-6-11-12-9(15-6)10-8(13)5-7-3-2-4-14-7/h2-8,16-17H,9-14H2,1H3,(H,28,32,34)(H,29,33,35);1-2,5,8H,3-4,6-7H2,(H,13,15,16);2-4H,5H2,1H3,(H,10,12,13)
InChIKeyGFVAGWCOQSWHIB-UHFFFAOYSA-N
MW1053.39 g/mol
LogP8.48
Rot. Bonds18

About N-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide

N-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide (PubChem CID 144630605) has the molecular formula C46H48N14O4S6 and a molecular weight of 1053.39 g/mol. Its IUPAC name is N-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide.

Molecular Properties

Compound NameN-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide
PubChem CID144630605
Molecular FormulaC46H48N14O4S6
Molecular Weight1053.39 g/mol
Exact Mass1052.23
IUPAC NameN-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide
SMILESCc1ccnc(CC(=O)Nc2nnc(CC3CC(Cc4nnc(NC(=O)Cc5ccccn5)s4)C3)s2)c1.Cc1nnc(NC(=O)Cc2cccs2)s1.O=C(Cc1cccs1)Nc1nnc(CC2CC2)s1
InChIInChI=1S/C25H26N8O2S2.C12H13N3OS2.C9H9N3OS2/c1-15-5-7-27-19(8-15)14-21(35)29-25-33-31-23(37-25)12-17-9-16(10-17)11-22-30-32-24(36-22)28-20(34)13-18-4-2-3-6-26-18;16-10(7-9-2-1-5-17-9)13-12-15-14-11(18-12)6-8-3-4-8;1-6-11-12-9(15-6)10-8(13)5-7-3-2-4-14-7/h2-8,16-17H,9-14H2,1H3,(H,28,32,34)(H,29,33,35);1-2,5,8H,3-4,6-7H2,(H,13,15,16);2-4H,5H2,1H3,(H,10,12,13)
InChIKeyGFVAGWCOQSWHIB-UHFFFAOYSA-N
XLogP8.48
TPSA245.30 Ų
H-Bond Donors4
H-Bond Acceptors20
Rotatable Bonds18
Heavy Atoms70
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001053.39
LogP ≤ 58.48
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1020

Analyze N-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide?
The IUPAC name of N-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide (CID 144630605) is N-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide.
What is the SMILES notation for N-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide?
The canonical SMILES for N-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide is Cc1ccnc(CC(=O)Nc2nnc(CC3CC(Cc4nnc(NC(=O)Cc5ccccn5)s4)C3)s2)c1.Cc1nnc(NC(=O)Cc2cccs2)s1.O=C(Cc1cccs1)Nc1nnc(CC2CC2)s1.
What is the InChIKey of N-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide?
The InChIKey is GFVAGWCOQSWHIB-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H26N8O2S2.C12H13N3OS2.C9H9N3OS2/c1-15-5-7-27-19(8-15)14-21(35)29-25-33-31-23(37-25)12-17-9-16(10-17)11-22-30-32-24(36-22)28-20(34)13-18-4-2-3-6-26-18;16-10(7-9-2-1-5-17-9)13-12-15-14-11(18-12)6-8-3-4-8;1-6-11-12-9(15-6)10-8(13)5-7-3-2-4-14-7/h2-8,16-17H,9-14H2,1H3,(H,28,32,34)(H,29,33,35);1-2,5,8H,3-4,6-7H2,(H,13,15,16);2-4H,5H2,1H3,(H,10,12,13).
What are the key properties of N-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide?
N-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide has a molecular weight of 1053.39 g/mol, XLogP of 8.48, 18 rotatable bonds, 4 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-(cyclopropylmethyl)-1,3,4-thiadiazol-2-yl]-2-thiophen-2-ylacetamide;N-[5-[[3-[[5-[[2-(4-methyl-2-pyridinyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]methyl]cyclobutyl]methyl]-1,3,4-thiadiazol-2-yl]-2-pyridin-2-ylacetamide;N-(5-methyl-1,3,4-thiadiazol-2-yl)-2-thiophen-2-ylacetamide is sourced from PubChem (CID 144630605), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).